Company Profile
Palatin Technologies, Inc. Stock Price, News & Analysis
- Ticker:
- PTN
- Exchange:
- NASDAQ
- Sector:
- Biotechnology
- Location:
- Headquartered in the United States and listed on NASDAQ, Palatin Technologies is followed within the biotech universe for its exposure to catalyst-driven execution.
Stock performance
11.21 USD (-4.76%)
Close
Last updated: June 23, 2026 at 00:00
19.95M USD
Market cap
Why the stock is moving
PTN is trading with a steady catalyst profile while investors wait for the next headline that changes the story.
Company overview
Business overview
Palatin Technologies is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, Palatin Technologies is followed within the biotech universe for its exposure to catalyst-driven execution.
Business Model Characteristics
Palatin Technologies follows a catalyst-driven model where the market watches how the company turns development work into repeatable value creation.
Position Within the Biotechnology Landscape
Compared with more mature healthcare peers, Palatin Technologies sits closer to the development side of the biotechnology landscape, where timing around data and approvals matters most.
Future catalysts
Recent news
The five most recent feed items are shown below in reverse chronological order.
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Palatin Technologies, Inc. (PTN)?
Palatin Technologies, Inc. (PTN) most recently closed at 11.21 USD, a -4.76% move versus the previous session.
What is the market cap of Palatin Technologies, Inc. (PTN)?
Palatin Technologies, Inc. currently has a market capitalization of 19.95M USD on BioPharmSignal.
What does Palatin Technologies, Inc. do?
Palatin Technologies is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
On which exchange is PTN stock listed?
Palatin Technologies, Inc. (PTN) is associated with NASDAQ, Headquartered in the United States and listed on NASDAQ, Palatin Technologies is followed within the biotech universe for its exposure to catalyst-driven execution., Biotechnology.
What is Palatin?
Palatin Technologies is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs.
Which conditions is Palatin Technologies, Inc. targeting with Palatin?
Palatin Technologies is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
What is Technologies?
Palatin Technologies is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs.
What is Investors?
Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.